Linda Hogle, PhD
Position title: Professor of Medical Social Sciences, Emerita
Phone: (608) 263-6954
Room 1440, Medical Sciences Center
- Stem cell and tissue engineering policy and ethics
- Socio-cultural, political and ethical issues in emerging biomedical engineering technologies
- Transnational issues in governance of novel technologies
- Linda F. Hogle and Amritava Das, “The social production of evidence: regenerative medicine and the 21st Century Cures Act,” Regenerative Medicine 12:6 (2017), 581-586. Special issue on social and ethical issues of regenerative medicine.
- Linda F. Hogle, “Data-intensive resourcing in healthcare,” BioSocieties 11:3 (2016), 372-393. Special issue on Big Data.
- Linda F. Hogle, “Characterizing Human Embryonic Stem Cells: Biological and Social Markers of Identity,” Medical Anthropology Quarterly 24:4 (2010), 433-450.
- Linda F. Hogle, “Pragmatic Objectivity and the Standardization of Engineered Tissues,” Social Studies of Science 39:5 (2009), 1-26.
- Linda F. Hogle, “Science, Ethics and the ‘Problems’ of Governing Nanotechnologies,” Journal of Law, Medicine & Ethics 37:4 (2009), 749–758.
- Raval, A., T. Kamp, and L. Hogle, “Cellular Therapies for Heart Disease: Unveiling the Ethical and Public Policy Challenges,” Journal of Molecular Cellular Cardiology 45:4 (2008), 593-601.
- Greely, H., Cho, M., Hogle, L.F., and Satz, D., “Thinking about the Human Neuron Mouse,” American Journal of Bioethics-Neuroethics 7:5 (2007), 27-34.